Back to Search
Start Over
A QALY is [still] a QALY is [still] a QALY?
- Source :
- BMC Medical Ethics, Vol 25, Iss 1, Pp 1-6 (2024)
- Publication Year :
- 2024
- Publisher :
- BMC, 2024.
-
Abstract
- Abstract Despite clinical evidence of drug superiority, therapeutic modalities, like combination immunotherapy, are mostly considered cost-ineffective due to their high costs per life year(s) gained. This paper, taking an ethical stand, reevaluates the standard cost-effectiveness analysis with that of the more recent justice-enhanced methods and concludes by pointing out the shortcomings of the current methodologies.
Details
- Language :
- English
- ISSN :
- 14726939
- Volume :
- 25
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- BMC Medical Ethics
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.4072fc174e1a43a5b35fa55330868e48
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s12910-024-01036-w